Maloff Protect: Now available for purchase without a prescription
Maloff Protect works by killing malaria parasites in your body. If taken before you are bitten, it can prevent you from becoming infected.
Until now, atovaquone/proguanil was only available with a doctor’s prescription. With Maloff Protect, you can get the same protection direct from us, making your travel preparations even simpler.
Preventing malaria is just one of the things to think about before you travel. There might also be some recommended vaccinations. If you haven't already done so, make an appointment to find out what other precautions you should take.
Call us now on 0161 870 6546 or if you prefer buy online here: https://www.clearchemist.co.uk/maloff-protect-24-tablets.html?___SID=U
Announcement from the Public Health service in England
Shortage of hepatitis A vaccines
Hepatitis A vaccine continues to be in short supply in the United Kingdom (UK) and globally; until normal vaccine supply resumes, some products may not be available or may be reserved for special risk groups However for standard travel requirements, this vaccination will not be available.
Shortage of hepatitis B vaccines
There is at present, a global shortage of hepatitis B vaccine which is currently impacting severely on the UK supply. The situation is particularly critical during August but limitations on supply are likely to continue until early 2018.
PHE and Department of Health (DH) have been working with both vaccine manufacturers to institute ordering restrictions according to customer type. As a consequence, NHS hospital trusts will get the highest allocation, and some providers, including community pharmacy and general practice, will not be able to order any adult hepatitis B vaccine stock until further notice.
POST EXPOSURE VACCINATION
If you have been subject to an assault or a needle-stick injury and require urgent post-exposure Hepatitis B vaccination, please visit either your GP or an urgent care/Accident & Emergency department at an NHS trust for a full assessment.
The situation is under constant review, to ensure that the available supply is able to match clinical need for the rest of the year. PHE has also developed patient and public facing materials which are published alongside this guidance which can be found by visiting:
Advice for travellers who cannot obtain these vaccinations and how to stay safe whilst abroad, please visit:
www.fitfortravel.nhs.uk and search for the vaccination via the ‘A-Z Index’ list.
Mulltiple countries are currently experiencing outbreaks of Zika virus infection, particularly countries in South and Central America and the Caribbean. Zika virus is
transmitted primarily by Aedes aegypti mosquitoes, which are not present in the UK;
almost all cases will be associated with transmission by mosquito bites in countries
with active Zika virus transmission.
Most people infected with Zika virus will have no symptoms, or will
experience a mild, short-lived illness that resolves spontaneously, following an incubation period of up to 14 days. However, some countries with active Zika virus transmission, particularly Brazil, have reported an increase in the number of babies being born with microcephaly and other congenital malformations, while Zika virus transmission is also occurring.
It is not yet proven that Zika virus infection of pregnant women causes microcephaly
and other congenital defects, but the scientific evidence is sufficient to act on a
precautionary basis and there is enough concern about the association between Zika
virus infection and microcephaly for the World Health Organization (WHO) to have
declared a Public Health Emergency of International Concern. Additionally, Guillain-
Barré syndrome and other neurological and autoimmune syndromes are being
reported in areas where Zika outbreaks have occurred although this appears to be
considerably rarer. (Travel Advice for prganant women - gov.uk)
Pregnant women and Zika virus infection
Efforts are focussed on trying to prevent Zika virus infections in pregnant women or in
women who are planning pregnancy. Such women should have pre-departure travel
advice that includes considering avoiding non-essential travel to countries with active
transmission until after pregnancy is concluded, and advice on measures that can be
taken to limit infection risk when travel is unavoidable.
A small number of cases of male-to-female sexual transmission of Zika virus have been reported, and advice about preventing sexual transmission is also available.
Other groups and Zika virus infection
Other travellers to, or other people arriving from countries with active Zika
transmission may present with symptoms suggestive of Zika virus infection, or have
concerns about Zika virus risks associated with travel. . Advice
has been produced for members of the public.
I reiterate that the risk to the UK population is very low, and that our efforts should be
focused on preventing Zika virus infection in pregnant women or women planning to
become pregnant, associated with travel to countries with active Zika virus
transmission. Additionally, women who may have been exposed to Zika virus and
who are pregnant or who are planning pregnancy require appropriate assessment
and advice - contact your GP if you are concerned in any way. Please call us on 0161 870 6546 for further guidance or click here to read the NHS overview.